Mouwasat (4002.SE) has started the trial operations for the expansion of Jubail hospital, which will continue for six weeks and will include experimenting the construction and medical systems. The project came after a delay of 12 months from the previously expected period, due to delays in licensing procedures for the construction works from government entities and will not result in any additional costs over the previous expected costs. The company cited that the construction did not impact the services provide at the existing hospital. (Company disclosure)   Mouwasat Medical Services: SAR113.00 as of 3 March 2016, Rating: Buy, FV: SAR135.00 per share, MCap: USD1,507 million, MOUWASAT AB / 4002.SE